BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 19, 2010
View Archived Issues
Schering and Southern Research Institute claim new therapeutics for HCV infection
Read More
GlaxoSmithKline identifies new HIF-PH inhibitors for treatment of anemia
Read More
GlaxoSmithKline discovers novel IFN-alpha inducers
Read More
Canadian researchers claim new androgen receptor antagonists for prostate cancer
Read More
FibroGen discovers novel HIF prolyl hydroxylase inhibitors
Read More
Preclinical data support therapeutic potential of AGS-16M8F in kidney and liver cancer
Read More
Macrophage migration inhibitory factor inhibitors active in bladder cancer, diabetes models
Read More
Interim data of phase I/II AGS-003 trial in mRCC show promising immune and clinical response
Read More
Interim clinical data on varenicline for smoking cessation in bipolar depression disclosed
Read More
Asenapine reduces depressive symptoms in bipolar I disorder
Read More
GW's Sativex advances towards approval in U.K. and Spain for spasticity due to MS
Read More
Regenerative Medicine Assets sells ICX-TRC hair regeneration therapy to Aderans Research Institute
Read More
MediciNova reports preliminary phase Ib results on MN-221 in COPD
Read More
CPEX presents preliminary phase IIa results of Nasulin in type 2 diabetes
Read More
FDA schedules Joint Advisory Committee Meeting regarding Acurox NDA
Read More
Biomarkers Consortium launches I-SPY 2 breast cancer trial
Read More
Achillion receives NIH grant to study antibacterials
Read More
Emisphere and Alchemia to develop oral formulation of fondaparinux anticoagulant
Read More
Pharming submits response to CHMP for Rhucin MAA for hereditary angioedema
Read More
Novelos discontinues development NOV-002 in NSCLC
Read More
Teva Pharmaceutical to acquire Ratiopharm
Read More
Stemedica files IND with FDA for phase I/II allogeneic mesenchymal stem cell trial for stroke
Read More
FDA approves Carbaglu for N-acetylglutamate synthase deficiency
Read More
PolyMedix begins phase Ib trial of PMX-60056 for reversal of heparin-induced anticoagulation
Read More
FDA approves Somaxon's Silenor for treatment of insomnia
Read More